Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.

Pina-Cabral T, Pereira J, Paulo-Fernandes J, Silva M, Fontes-Sousa M, Anacleto M, Lobo-Martins S, Mirco A, Miranda H, Martins A, Cavaco P

Open source

DOI
10.3390/cancers18010076
Published
2025 Dec 25
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18010076,
  title = {Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.},
  author = {Pina-Cabral T and Pereira J and Paulo-Fernandes J and Silva M and Fontes-Sousa M and Anacleto M and Lobo-Martins S and Mirco A and Miranda H and Martins A and Cavaco P},
  year = {2025},
  journal = {Cancers},
  doi = {10.3390/cancers18010076},
  url = {https://doi.org/10.3390/cancers18010076}
}

RIS

TY  - JOUR
TI  - Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.
AU  - Pina-Cabral T
AU  - Pereira J
AU  - Paulo-Fernandes J
AU  - Silva M
AU  - Fontes-Sousa M
AU  - Anacleto M
AU  - Lobo-Martins S
AU  - Mirco A
AU  - Miranda H
AU  - Martins A
AU  - Cavaco P
PY  - 2025
JO  - Cancers
DO  - 10.3390/cancers18010076
UR  - https://doi.org/10.3390/cancers18010076
ER  - 

APA

T, P., J, P., J, P., M, S., M, F., M, A., S, L., A, M., H, M., A, M., & P, C. (2025). Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance.. Cancers. https://doi.org/10.3390/cancers18010076

Source records